Athernal Bio
Pre-clinicalAthernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
Biologics